UCB Pharma (France)

UCB Pharma (France)

UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for UCB Pharma (France), France, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

52%


Total
Publications

169


Total Open
Publications

88


Total
Citations

2.3K


Open Access
Percentage

52%


Total
Publications

169


Total Open
Publications

88


Total
Citations

2.3K

Wikipedia

Website

download

Breakdown

32% 17% 3% 48%

Publisher Open

32%

Both

17%

Other Platform Open

3%

Closed

48%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

21%OA Journal

OA Journal 21%

17

Hybrid 43%

35

No Guarantees 36%

30

Other Platform Open

Domain 65%

22

Institution 59%

20

Other Internet 18%

6

Preprint 0%

0

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
22
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
8
University of Edinburgh - Edinburgh Research Explorer
Institution
7
University College London - UCL Discovery
Institution
6
Europe PMC
Domain
6
Universitat Pompeu Fabra - Repositori digital de la UPF
Institution
4
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
4
University College Cork - Cork Open Research Archive
Institution
3
RCAAP Project by FCT - Portuguese National Funding Agency for Science, Research and Technology - RCAAP Search Portal
Institution
3
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
3
1 / 6

Data updated 7 October 2024

Share

Share

Share